|

Tobevibart Clinical Trials

1 actively recruiting trial

Also known as: VIR-3434

Pipeline

Phase 3: 1

Top Sponsors

  • Vir Biotechnology, Inc.1

Indications

  • Viral Hepatitis1
  • Liver Disease1

Other1 trial

A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.